A novel alkaloid compound, DCZ0358, exerts significant antitumor activity in bortezomib-resistant multiple myeloma cells through inhibition of JAK2/STAT3 pathway-Reference-Cited by-同舟云学术

A novel alkaloid compound, DCZ0358, exerts significant antitumor activity in bortezomib-resistant multiple myeloma cells through inhibition of JAK2/STAT3 pathway

Published:2023-02-01 Issue:2 Volume:55 Page:215-224
ISSN:1672-9145
Container-title:Acta Biochimica et Biophysica Sinica
language:en
Short-container-title:ABBS

Author:

Zhang Bibo,Li Bo,Xie Yongsheng,Chang Shuaikang,Xu Zhijian,Hu Huifang,Chen Gege,Zhang Ting,He Jun,Wu Xiaosong,Zhu Huabin,Lai Weiming,Song Dongliang,Lu Ying,Jia Xinyan,Zhu Weiliang,Shi Jumei

Publisher

China Science Publishing & Media Ltd.

Subject

General Medicine,Biochemistry,Biophysics

Link

https://engine.scichina.com/doi/pdf/CFDA1C2A03BB456C9B9A6BA7A7495DCF

Reference32 articles.

1. Pawlyn C, Davies FE. Toward personalized treatment in multiple myeloma based on molecular characteristics. Blood, 2019, 133: 660-675.

2. Joshua DE, Bryant C, Dix C, Gibson J, Ho J. Biology and therapy of multiple myeloma. Med J Australia, 2019, 210: 375-380.

3. Dimopoulos MA, Jakubowiak AJ, McCarthy PL, Orlowski RZ, Attal M, Bladé J, Goldschmidt H. Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma. Blood Cancer J, 2020, 10:

4. Laubach J, Garderet L, Mahindra A, Gahrton G, Caers J, Sezer O, Voorhees P. Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group. Leukemia, 2016, 30: 1005-1017.

5. Arora L, Kumar A, Arfuso F, Chng W, Sethi G. The role of signal transducer and activator of transcription 3 (STAT3) and its targeted inhibition in hematological malignancies. Cancers, 2018, 10:

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The ERK1/2-Elk1, JNK-cJun, and JAK-STAT Transcriptional Axes as Potential Bortezomib Resistance Mediators in Prostate Cancer;2024-04-20

2. Berberine derivative DCZ0358 induce oxidative damage by ROS-mediated JNK signaling in DLBCL cells;International Immunopharmacology;2023-12